In April 2026, EPA released a proposal that, if finalized, would begin the process to potentially regulate the presence of pharmaceuticals in drinking water, by designating them as “Candidate Contaminants.”  This proposal is likely to be of significant interest to pharmaceutical manufacturers, given that it entails EPA evaluating, in detail…